USD 59.86
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| RDNT | -1.7 | -14.8 | -21.8 | -12.4 | -4.0 | 64.9 | 124.3 | 189.3 | 638.1 | 7989.2 |
| S&P 500 | 1.0 | 1.8 | -0.9 | 2.7 | 7.3 | 26.5 | 31.0 | 80.1 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | RDNT |
| name | RadNet, Inc. |
| price | 59.86 |
| changes percentage | -1.6754 |
| change | -1.02 |
| day low | 59.29 |
| day high | 61.77 |
| year high | 93.65 |
| year low | 35.16 |
| market cap | 4431238262 |
| price avg 50 | 75.5904 |
| price avg 200 | 64.0529 |
| exchange | NASDAQ |
| volume | 808109 |
| avg volume | 563232 |
| open | 61.77 |
| previous close | 60.88 |
| eps | -0.07 |
| pe | -855.14 |
| earnings announcement | 2025-02-26T10:59:00.000+0000 |
| shares outstanding | 74026700 |
| timestamp | 2025-01-17 21:00:01 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000790526 | |||
| revenue | 1616630000 | 1430061000 | 13.05 |
| gross profit | 221391000 | 165715000 | 33.60 |
| gross profit ratio | 0.14 | 0.12 | 18.18 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 122694000 | 115877000 | 5.88 |
| interest income | 0 | 11220000 | -100.00 |
| interest expense | 64483000 | 50841000 | 26.83 |
| ebitda | 292786000 | 278534000 | 5.12 |
| ebitdaratio | 0.18 | 0.17 | 6.53 |
| operating income | 98697000 | 46363000 | 112.88 |
| operating income ratio | 0.06 | 0.03 | 88.31 |
| net income | 3044000 | 33608000 | -90.94 |
| net income ratio | 0.0 | 0.02 | -91.99 |
| eps | 0.05 | 0.6 | -92.02 |
Revenue Growth: revenue increased to 1,617 million in 2023 from 1,430 million in 2022 representing a change of 13.05%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 221 million in 2023 from 166 million in 2022 representing a change of 33.6%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 293 million in 2023 from 279 million in 2022 representing a change of 5.12%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 99 million in 2023 from 46 million in 2022 representing a change of 112.88%. The increase in operating income indicates better operational performance and increased profitability.
Operating Expenses: Operating Expenses increased to 123 million in 2023 from 116 million in 2022 representing a change of 5.88%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Net Income: Net income decreased to 3 million in 2023 from 34 million in 2022 representing a change of -90.94%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.05 in 2023 from 0.05 in 2022 representing a change of -92.02%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000790526 | |||
| revenue | 461142000 | 459714000 | 0.31 |
| gross profit | 460994000 | 35515000 | 1198.03 |
| gross profit ratio | 1.0 | 0.08 | 1194.01 |
| research and development expenses | 0 | 3317000 | -100.00 |
| operating expenses | 427231000 | 34475000 | 1139.25 |
| interest income | 0 | 0 | NaN |
| interest expense | 19427000 | 26082000 | -25.52 |
| ebitda | 427818000 | 69990000 | 511.26 |
| ebitdaratio | 0.93 | 0.15 | 509.36 |
| operating income | 33911000 | 34846000 | -2.68 |
| operating income ratio | 0.07 | 0.08 | -2.98 |
| net income | 20926000 | -2982000 | 801.74 |
| net income ratio | 0.05 | -0.01 | 799.57 |
| eps | 0.28 | -0.04 | 789.66 |
Revenue Growth: revenue increased to 461 million in 2024Q3 from 460 million in 2024Q2 representing a change of 0.31%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 461 million in 2024Q3 from 36 million in 2024Q2 representing a change of 1198.03%. This indicates a sales profitability growth, which is a positive sign for the company.
Net Income: Net income increased to 21 million in 2024Q3 from -3 million in 2024Q2 representing a change of 801.74%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.28 in 2024Q3 from 0.28 in 2024Q2 representing a change of 789.66%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q3 from 3 million in 2024Q2 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Expenses: Operating Expenses increased to 427 million in 2024Q3 from 34 million in 2024Q2 representing a change of 1139.25%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 428 million in 2024Q3 from 70 million in 2024Q2 representing a change of 511.26%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 34 million in 2024Q3 from 35 million in 2024Q2 representing a change of -2.68%. The decrease in operating income indicates worse operational performance and decreased profitability.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000790526 | |||
| total assets | 2690473000 | 2433907000 | 10.54 |
| total liabilities | 1877114000 | 1942455000 | -3.36 |
| total equity | 813359000 | 491452000 | 65.50 |
| cash and cash equivalents | 342570000 | 127834000 | 167.98 |
| short term investments | 0 | 0 | NaN |
| long term investments | 92710000 | 57893000 | 60.14 |
| total current assets | 579276000 | 367184000 | 57.76 |
| total non current assets | 2111197000 | 2066723000 | 2.15 |
| total current liabilities | 437452000 | 466723000 | -6.27 |
| total non current liabilities | 1439662000 | 1475732000 | -2.44 |
| common stock | 7000 | 6000 | 16.67 |
| retained earnings | -79578000 | -82622000 | 3.68 |
| total debt | 1491120000 | 1513468000 | -1.48 |
Total Assets: Total Assets increased to 2,690 million in 2023 from 2,434 million in 2022 representing a change of 10.54%. Suggesting a growth in asset holdings.
Total Liabilities: Total Liabilities decreased to 1,877 million in 2023 from 1,942 million in 2022 representing a change of -3.36%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 813 million in 2023 from 491 million in 2022 representing a change of 65.5%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 343 million in 2023 from 128 million in 2022 representing a change of 167.98%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 579 million in 2023 from 367 million in 2022 representing a change of 57.76%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 437 million in 2023 from 467 million in 2022 representing a change of -6.27%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 16.67%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to -80 million in 2023 from -83 million in 2022 representing a change of 3.68%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 1,491 million in 2023 from 1,513 million in 2022 representing a change of -1.48%. This indicates a reduction in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000790526 | |||
| total assets | 3275342000 | 3229423000 | 1.42 |
| total liabilities | 2155708000 | 2136583000 | 0.90 |
| total equity | 1119634000 | 1092840000 | 2.45 |
| cash and cash equivalents | 748916000 | 741679000 | 0.98 |
| short term investments | 0 | 0 | NaN |
| long term investments | 104514000 | 100844000 | 3.64 |
| total current assets | 1016253000 | 1004724000 | 1.15 |
| total non current assets | 2259089000 | 2224699000 | 1.55 |
| total current liabilities | 470130000 | 474201000 | -0.86 |
| total non current liabilities | 1685578000 | 1662382000 | 1.40 |
| common stock | 7000 | 7000 | 0.00 |
| retained earnings | -82130000 | -85339000 | 3.76 |
| total debt | 1736835000 | 1718243000 | 1.08 |
Total Assets: Total Assets increased to 3,275 million in 2024Q3 from 3,229 million in 2024Q2 representing a change of 1.42%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 1,120 million in 2024Q3 from 1,093 million in 2024Q2 representing a change of 2.45%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 749 million in 2024Q3 from 742 million in 2024Q2 representing a change of 0.98%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 1,016 million in 2024Q3 from 1,005 million in 2024Q2 representing a change of 1.15%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 470 million in 2024Q3 from 474 million in 2024Q2 representing a change of -0.86%. This indicates a lower short-term debt burden.
Retained Earnings: Retained Earnings increased to -82 million in 2024Q3 from -85 million in 2024Q2 representing a change of 3.76%. This indicates an accumulated profits.
Total Liabilities: Total Liabilities increased to 2,156 million in 2024Q3 from 2,137 million in 2024Q2 representing a change of 0.9%. This indicates an increase in overall liabilities.
Total Debt: Total Debt increased to 1,737 million in 2024Q3 from 1,718 million in 2024Q2 representing a change of 1.08%. This indicates an increase in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000790526 | |||
| net change in cash | 214736000 | -6772000 | 3270.94 |
| operating cash flow | 220863000 | 146417000 | 50.85 |
| free cash flow | 44263000 | -102995000 | 142.98 |
| capital expenditure | -176600000 | -249412000 | 29.19 |
| depreciation and amortization | 189493000 | 184724000 | 2.58 |
| deferred income tax | 6056000 | 13356000 | -54.66 |
| stock based compensation | 26785000 | 23770000 | 12.68 |
| accounts payables | 15086000 | 49778000 | -69.69 |
| inventory | 0 | 0 | NaN |
| acquisitions net | -14035000 | -1441000 | -873.98 |
| investments in property plant and equipment | -176600000 | -249412000 | 29.19 |
| net cash used for investing activites | -201470000 | -246949000 | 18.42 |
| debt repayment | -43993000 | 94246000 | -146.68 |
| common stock issued | 245832000 | 294000 | 83516.33 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 195635000 | 93647000 | 108.91 |
| cash at end of period | 342570000 | 127834000 | 167.98 |
| accounts receivables | 2650000 | -30078000 | 108.81 |
| cash at beginning of period | 127834000 | 134606000 | -5.03 |
Net Change in Cash: Net Change in Cash increased to 215 million in 2023 from -7 million in 2022 representing a change of 3270.94%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 221 million in 2023 from 146 million in 2022 representing a change of 50.85%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 44 million in 2023 from -103 million in 2022 representing a change of 142.98%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables decreased to 15 million in 2023 from 50 million in 2022 representing a change of -69.69%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Capital Expenditure: Capital Expenditure increased to -177 million in 2023 from -249 million in 2022 representing a change of 29.19%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 27 million in 2023 from 24 million in 2022 representing a change of 12.68%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Receivables: Accounts Receivables increased to 3 in 2023 from -30 million in 2022 representing a change of 108.81%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000790526 | |||
| operating cash flow | 57404000 | 116005000 | -50.52 |
| free cash flow | 49106000 | 69319000 | -29.16 |
| capital expenditure | -8298000 | -46686000 | 82.23 |
| depreciation and amortization | 34979000 | 20132000 | 73.75 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 4723000 | 4748000 | -0.53 |
| accounts receivables | -3788000 | 0 | NaN |
| accounts payables | -409000 | 50996000 | -100.80 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 28593000 | -29241000 | 197.78 |
| investments in property plant and equipment | 104095000 | -46686000 | 322.97 |
| net cash used for investing activites | -50148000 | -77341000 | 35.16 |
| debt repayment | -7663000 | 181784000 | -104.22 |
| common stock issued | -367000 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -166000 | 176106000 | -100.09 |
| net change in cash | 7237000 | 214699000 | -96.63 |
| cash at end of period | 748916000 | 741679000 | 0.98 |
| cash at beginning of period | 741679000 | 526980000 | 40.74 |
Net Change in Cash: Net Change in Cash decreased to 7 million in 2024Q3 from 215 million in 2024Q2 representing a change of -96.63%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow decreased to 57 million in 2024Q3 from 116 million in 2024Q2 representing a change of -50.52%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 49 million in 2024Q3 from 69 million in 2024Q2 representing a change of -29.16%. This indicates a decrease in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -8 million in 2024Q3 from -47 million in 2024Q2 representing a change of 82.23%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation decreased to 5 million in 2024Q3 from 5 million in 2024Q2 representing a change of -0.53%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 51 million in 2024Q2 representing a change of -100.8%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to -4 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 25.43 | 25.4 | 0.09 |
| net income per share | 0.05 | 0.6 | -91.98 |
| operating cash flow per share | 3.47 | 2.6 | 33.56 |
| free cash flow per share | 0.7 | -1.83 | 138.05 |
| cash per share | 5.39 | 2.27 | 137.27 |
| book value per share | 12.79 | 8.73 | 46.53 |
| tangible book value per share | 0.68 | -5.19 | 113.10 |
| shareholders equity per share | 9.92 | 5.92 | 67.69 |
| interest debt per share | 24.47 | 27.79 | -11.95 |
| market cap | 2210678651.43 | 1060003516.88 | 108.55 |
| enterprise value | 3359228651.43 | 2445637516.88 | 37.36 |
| pe ratio | 726.24 | 31.54 | 2202.59 |
| price to sales ratio | 1.37 | 0.74 | 84.49 |
| pocfratio | 10.01 | 7.24 | 38.26 |
| pfcf ratio | 49.94 | -10.29 | 585.28 |
| pb ratio | 3.51 | 3.18 | 10.11 |
| ptb ratio | 3.51 | 3.18 | 10.11 |
| ev to sales | 2.08 | 1.71 | 21.50 |
| enterprise value over ebitda | 11.47 | 8.78 | 30.67 |
| ev to operating cash flow | 15.21 | 16.7 | -8.94 |
| ev to free cash flow | 75.89 | -23.75 | 419.61 |
| earnings yield | 0.0 | 0.03 | -95.66 |
| free cash flow yield | 0.02 | -0.1 | 120.61 |
| debt to equity | 2.36 | 4.55 | -47.98 |
| debt to assets | 0.55 | 0.62 | -10.87 |
| net debt to ebitda | 3.92 | 4.97 | -21.14 |
| current ratio | 1.32 | 0.79 | 68.32 |
| interest coverage | 1.53 | 0.91 | 67.84 |
| income quality | 72.56 | 4.36 | 1565.44 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.29 | 0.32 | -11.13 |
| capex to operating cash flow | 0.8 | 1.7 | -53.06 |
| capex to revenue | 0.11 | 0.17 | -37.36 |
| capex to depreciation | 0.93 | 1.35 | -30.98 |
| stock based compensation to revenue | 0.02 | 0.02 | -0.32 |
| graham number | 3.27 | 8.91 | -63.33 |
| roic | 0.03 | 0.02 | 91.52 |
| return on tangible assets | 0.0 | 0.02 | -92.22 |
| graham net net | -21.91 | -29.77 | 26.41 |
| working capital | 141824000 | -99539000 | 242.48 |
| tangible asset value | 43281000 | -292441000 | 114.80 |
| net current asset value | -1297838000 | -1575271000 | 17.61 |
| invested capital | 2112335000 | 1853839000 | 13.94 |
| average receivables | 187188500 | 162887000 | 14.92 |
| average payables | 112783000 | 94569500 | 19.26 |
| average inventory | 0 | 0 | NaN |
| days sales outstanding | 42.68 | 47.3 | -9.76 |
| days payables outstanding | 32.15 | 29.64 | 8.45 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 8.55 | 7.72 | 10.82 |
| payables turnover | 11.35 | 12.31 | -7.80 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.0 | 0.1 | -95.22 |
| capex per share | 2.78 | 4.43 | -37.31 |
ROE: Return on Equity (ROE) decreased to 0.00 on 2023-12-31 from 0.10 on 2022-12-31, representing a change of -95.22%. Suggesting that the company has not been generating high returns for its shareholders.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 2.36 on 2023-12-31 from 4.55 on 2022-12-31, representing a change of -47.98%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 726.24 on 2023-12-31 from 31.54 on 2022-12-31, representing a change of 2202.59%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.32 on 2023-12-31 from 0.79 on 2022-12-31, representing a change of 68.32%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| RDNT | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 6.27 | 6.26 | 0.21 |
| net income per share | 0.28 | -0.04 | 801.02 |
| operating cash flow per share | 0.78 | 1.58 | -50.57 |
| free cash flow per share | 0.67 | 0.94 | -29.23 |
| cash per share | 10.19 | 10.1 | 0.87 |
| book value per share | 15.23 | 14.88 | 2.35 |
| tangible book value per share | 4.4 | 4.08 | 7.74 |
| shareholders equity per share | 12.18 | 12.0 | 1.52 |
| interest debt per share | 23.9 | 23.76 | 0.58 |
| market cap | 5099797857.51 | 4298689710.2 | 18.64 |
| enterprise value | 6087716857.51 | 5275253710.2 | 15.40 |
| pe ratio | 60.93 | -360.39 | 116.91 |
| price to sales ratio | 11.06 | 9.35 | 18.27 |
| pocfratio | 88.84 | 37.06 | 139.75 |
| pfcf ratio | 103.85 | 62.01 | 67.47 |
| pb ratio | 5.7 | 4.88 | 16.74 |
| ptb ratio | 5.7 | 4.88 | 16.74 |
| ev to sales | 13.2 | 11.48 | 15.04 |
| enterprise value over ebitda | 14.23 | 75.37 | -81.12 |
| ev to operating cash flow | 106.05 | 45.47 | 133.21 |
| ev to free cash flow | 123.97 | 76.1 | 62.90 |
| earnings yield | 0.0 | -0.0 | 691.51 |
| free cash flow yield | 0.01 | 0.02 | -40.29 |
| debt to equity | 1.94 | 1.95 | -0.54 |
| debt to assets | 0.53 | 0.53 | -0.34 |
| net debt to ebitda | 2.31 | 13.95 | -83.45 |
| current ratio | 2.16 | 2.12 | 2.02 |
| interest coverage | 1.75 | 1.34 | 30.65 |
| income quality | 1.89 | -38.9 | 104.86 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0.01 | -100.00 |
| intangibles to total assets | 0.24 | 0.25 | -1.00 |
| capex to operating cash flow | 0.14 | 0.4 | -64.08 |
| capex to revenue | 0.02 | 0.1 | -82.28 |
| capex to depreciation | 0.24 | 2.32 | -89.77 |
| stock based compensation to revenue | 0.01 | 0.01 | -0.83 |
| graham number | 8.83 | 3.31 | 166.78 |
| roic | 0.01 | 0.01 | 66.76 |
| return on tangible assets | 0.01 | -0.0 | 789.67 |
| graham net net | -17.11 | -16.71 | -2.42 |
| working capital | 546123000 | 530523000 | 2.94 |
| tangible asset value | 323352000 | 299811000 | 7.85 |
| net current asset value | -1139455000 | -1131859000 | -0.67 |
| invested capital | 2653022000 | 2600515000 | 2.02 |
| average receivables | 211792500 | 224175000 | -5.52 |
| average payables | 346317500 | 339238000 | 2.09 |
| average inventory | 0 | 0.5 | -100.00 |
| days sales outstanding | 38.85 | 43.95 | -11.60 |
| days payables outstanding | 205988.72 | 75.08 | 274242.10 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 2.32 | 2.05 | 13.13 |
| payables turnover | 0.0 | 1.2 | -99.96 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.02 | -0.0 | 790.50 |
| capex per share | 0.11 | 0.64 | -82.24 |
ROE: Return on Equity (ROE) increased to 0.02 on 2024-09-30 Q3 from -0.00 on 2024-06-30 Q2, representing a change of 790.50%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 60.93 on 2024-09-30 Q3 from -360.39 on 2024-06-30 Q2, representing a change of 116.91%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 2.16 on 2024-09-30 Q3 from 2.12 on 2024-06-30 Q2, representing a change of 2.02%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio:
Negative Sentiment: Discounted Cash Flow value is -17.23 which is lower than current price 59.86, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Neutral
Publish Date: 2025-01-08 06:00:00
LOS ANGELES, Jan. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer and Dr. Gregory Sorensen, Executive Vice President and Chief Science Officer will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 3:00 p.m. PST.
Sentiment: Positive
Publish Date: 2024-12-04 13:30:00
CAMBRIDGE, Mass. , Dec. 4, 2024 /PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has selected Ketryx to accelerate the delivery of AI-powered health informatics solutions.
Sentiment: Positive
Publish Date: 2024-12-03 16:20:34
None of our picks is Nvidia or Amazon or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.
Sentiment: Positive
Publish Date: 2024-12-03 11:20:16
RadNet's latest collaboration aims to create an AI-powered SmartTechnology to improve patient experience and operational efficiency in ultrasound.
Sentiment: Positive
Publish Date: 2024-12-02 12:31:08
RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.
Sentiment: Positive
Publish Date: 2024-12-02 06:00:00
LOS ANGELES, Dec. 02, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the BofA Securities 2024 Leveraged Finance Conference in Boca Raton, FL on Tuesday, December 3, 2024 at 8:10 a.m. Eastern Time (5:10 a.m. Pacific Time).
Sentiment: Positive
Publish Date: 2024-12-02 06:00:00
LOS ANGELES and SOMERVILLE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population health screening programs, and efficient large-scale imaging operations. Moreover, DeepHealth launches SmartTechnology™ solutions that integrate advanced AI and informatics with imaging systems for more efficient, patient-centric workflows. This comprehensive portfolio, anchored on the cloud-native DeepHealth OS, is designed to improve operational efficiency, enhance clinical confidence, while elevating the experiences of patients and care teams. DeepHealth has established strategic collaborations with industry leaders in healthcare, medical imaging, AI, and cloud platforms to continuously innovate solutions, business models, and new care paradigms with the aim of empowering breakthroughs in care by unlocking the value of imaging.
Sentiment: Positive
Publish Date: 2024-12-01 12:00:00
LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware. The collaboration will combine Siemens Healthineers' Acuson Sequoia ultrasound system, RadNet's expertise in high-volume outpatient care, and DeepHealth's SmartSonography™ solution powered by the cloud-native DeepHealth OS to tackle workflow and workforce challenges for enhanced operational efficiency and better patient experience.
Sentiment: Positive
Publish Date: 2024-12-01 09:00:00
WILMINGTON, Del.--(BUSINESS WIRE)--Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet.
Sentiment: Positive
Publish Date: 2024-12-01 07:00:00
LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced a strategic collaboration with CARPL.ai, a leading AI orchestration company that enables radiologists to access, assess, and integrate radiology AI solutions in their workflows. DeepHealth will use CARPL.ai's technology to develop an AI control system that can be commercialized and will be designed to monitor and optimize imaging AI performance for improved clinical outcomes, operational efficiency, and accelerated adoption of AI in radiology. AI monitoring is crucial to ensure reliable, accurate, and unbiased performance.
Sentiment: Positive
Publish Date: 2024-11-29 09:43:00
SOMERVILLE, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Friday, November 29th by RadNet, Inc. (NASDAQ: RDNT), please note that in the third sentence of the first paragraph, the year that SmartMammo Dx was first cleared should be 2021, not 2012. The corrected release follows:
Sentiment: Negative
Publish Date: 2024-11-29 06:00:00
SOMERVILLE, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo1, is now FDA-cleared to be compatible with GE HealthCare's Senographe Pristina™ mammography systems. SmartMammo Dx was first cleared in May 2012 in conjunction with HOLOGIC mammography systems, where its performance has also been tested and cleared in patients with unilateral breasts and with breast implants. This newly expanded clearance advances DeepHealth's mission to enhance and expand breast cancer screening programs by broadening system compatibility.
Sentiment: Positive
Publish Date: 2024-11-22 11:00:00
LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has completed pricing and allocations for Amendment No. 1 to Credit and Guaranty Agreement (the “First Amendment”) which will reduce the interest rates payable under its Third Amended and Restated First Lien Credit and Guaranty Agreement (the “Credit Agreement”).
Sentiment: Positive
Publish Date: 2024-11-11 22:34:33
RadNet, Inc. (NASDAQ:RDNT ) Q3 2024 Earnings Conference Call November 11, 2024 10:30 AM ET Company Participants Mark Stolper - Executive Vice President & Chief Financial Officer Howard Berger - President & Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies John Ransom - Raymond James Larry Solow - CJS Securities Jim Sidoti - Sidoti & Co. Operator Good day, and welcome to the RadNet, Inc., Third Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.
Sentiment: Neutral
Publish Date: 2024-11-11 10:42:12
Radnet Inc (NASDAQ:RDNT) stock is soaring, last seen up 24% to trade at $89.11 at last glance, after the company reported better-than-expected earnings and revenue for the third quarter.
Sentiment: Positive
Publish Date: 2024-11-11 06:00:00
LOS ANGELES, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology™ solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping increase the efficiency of imaging interpretation and reporting, enabling collaboration across care teams, improving the clinical interpretation of images, and enhancing operational efficiency and productivity. These new SmartTechnology solutions will seek to combine GE HealthCare's imaging expertise and scale, RadNet's deep experience in care delivery, and DeepHealth's AI-powered health informatics portfolio to elevate patient care through improved end-to-end clinical and operational workflows.
Sentiment: Positive
Publish Date: 2024-11-11 06:00:00
CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology™ solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping i.
Sentiment: Neutral
Publish Date: 2024-11-10 16:15:00
LOS ANGELES, Nov. 10, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 399 owned and operated outpatient imaging centers, today reported financial results for its third quarter of 2024.
Sentiment: Positive
Publish Date: 2024-11-05 14:47:34
None of our picks is Nvidia or Amazon or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.
Sentiment: Positive
Publish Date: 2024-11-04 11:01:09
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
